GPGI is a highly speculative, recently assembled industrial roll-up trading at a $4B market cap with massive execution risk. The core CompoSecure business is genuinely strong (~$500M revenue, 35%+ EBITDA margins, growing 15-20%), but the $5B Husky acquisition has dramatically changed the risk profile. Husky's EBITDA collapsed 40% in Q1 2026, the CEO and CFO abruptly resigned, a short-seller has alleged accounting irregularities, and a securities investigation is underway. The acquisition was funded with $2B in debt (creating ~$150M+ annual interest burden) and $2B in equity that diluted shareholders by 155%. Even in a recovery scenario where Husky returns to $400M+ EBITDA and CompoSecure continues compounding, the combined entity might generate $250M in FCF against a $4B+ enterprise value — not compelling given the risk. The 30% short interest, accounting allegations, and management turnover at the acquired entity create significant downside tail risk. This is an 'avoid' until the Husky turnaround is demonstrably on track and the accounting concerns are resolved.